drugset / Trial / NCT02057198

Impact of Oral Antibiotic Treatment on C. Difficile

NCT02057198

Phase 4 Completed 33 enrolled Duke University
RandomizedParallel-groupOpen-labelTreatment

Summary

The overall aim is to characterize and to compare the extent and quantity of C. difficile stool shedding, perianal colonization and environmental contamination in patients who received oral fidaxomicin, oral metronidazole, or oral vancomycin. This is a prospective, randomized, microbiologic and molecular, study of environmental contamination from patients with proven C. difficile associated diarrhea (CDAD).

Timeline

Start
2014-06-10
Primary completion
2017-06-27
Completion
2017-06-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fidaxomicin Other / unclassified 200 mg Oral
Comparator Metronidazole Small molecule 500 mg Oral
Comparator Vancomycin Other / unclassified 125 mg Oral